Andrew J. Amin-Reimer

Andrew J. Amin-Reimer is an accomplished expert in research and development within the medical technology field, currently serving as the Director of Research Development for Cordis since October 2023. Prior to this role, Andrew held the position of Director of Research Development at MedAlliance Swiss Medical Technology, where significant achievements included obtaining FDA Investigational Device Exemption (IDE) approval for the first limus Drug Eluting Balloon (DEB) technology in the USA, as well as leading a successful strategy that resulted in four IDE approvals within eight months. Andrew's extensive experience includes roles as a Senior Research and Development Engineer and Validation Engineer at Roche, where contributions included drafting site-wide Master Validation Plans and conducting Failure Mode Effects Analysis. Academic qualifications include a Bachelor of Science in Biomedical Engineering and a Master of Science in Bioengineering from the University of California institutions.